NeuroOne Medical Technologies Corporation reported earnings results for the full year ended September 30, 2023. For the full year, the company reported net loss was USD 11.86 million compared to USD 10 million a year ago. Basic loss per share from continuing operations was USD 0.65 compared to USD 0.63 a year ago.
NeuroOne Medical Technologies Corporation
Equities
NMTC
US64130M2098
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8175 USD | -1.51% |
|
-14.32% | -48.26% |
06-20 | NeuroOne Says OneRF Ablation System Gets Procedure Code From CMS | MT |
06-20 | Neuroone Medical Technologies Corporation Receives Approval of ICD-10 Procedure Code for sEEG RF Ablation | CI |
1st Jan change | Capi. | |
---|---|---|
-48.26% | 22.76M | |
-33.94% | 14.68B | |
-52.23% | 2.36B | |
+23.01% | 1.94B | |
-10.06% | 1.5B | |
+21.17% | 1.23B | |
-23.46% | 880M | |
+1.91% | 782M | |
-34.13% | 752M | |
+23.82% | 593M |
- Stock Market
- Equities
- NMTC Stock
- News NeuroOne Medical Technologies Corporation
- NeuroOne Medical Technologies Corporation Reports Earnings Results for the Full Year Ended September 30, 2023